Lakewood-Amedex, Inc. Patent Portfolio Summary


Lakewood-Amedex has several families of patents in different technology sectors. However, the Company’s focus is on developing its Bisphosphocin antimicrobials for the treatment of several serious bacterial infection indications where antibiotic-resistant pathogens are particularly prevalent. The Company’s drug candidate for most of these indications is Nu-8, a new member of the Bisphosphocin class. Lakewood-Amedex has recently filed a broad patent application on this compound that if granted will provide protection until at least 2038. The Company has also recently filed a patent application on its proprietary Nu-3 gel formulation, which it intends to use in clinical trials for the treatment of chronic diabetic foot ulcers. If granted, this patent will provide protection until at least 2038.

Patent Family 1

 

CountryTitleFiling DateApplication No.Patent No.Status 
AustraliaANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/20182018230805N/APending
BrazilANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/20181120190186158N/APending
CanadaANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/20183055932N/APending
ChinaANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/2018201880030624.4

 

N/APublished
EuropeANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/201818763136.1

 

N/APublished
Hong KongANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/201862020007940.3Pending
IndiaANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/2018201927040425

 

N/APending
JapanANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/20182019-570355

 

N/APending
KoreaANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/201810-2019-7029037

 

N/APublished
MexicoANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/2018MX/a/2019/010695

 

N/APending
New ZealandANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/2018757711N/APending
United StatesANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/201816/492861N/APending
United StatesANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/201816/505497N/AAllowed
United StatesANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/201816/505501N/AAllowed
WOANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/2018PCT/US2018/022068

 

N/AExpired
WOANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF03/12/2018PCT/US2018/022071

 

N/AExpired

 

Patent Family 2

 

CountryTitleFiling DateApplication No.Patent No.Status 
AustraliaBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/20182018282905N/APending
BrazilBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/2018BR112019026073-0N/APending
CanadaBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/20183066722N/APending
ChinaBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/2018201880038759.5

 

N/APublished
EuropeBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/201818816615.1N/APublished
Hong KongBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/201818816615.1N/APending
IndiaBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/2018201927053712

 

N/APending
JapanBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/20182019-567981

 

N/APending
KoreaBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/20181020207000424

 

N/APending
MexicoBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/2018MX/a/2019/014772

 

N/APending
New ZealandBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/2018759577

 

N/APending
United StatesBISPHOSPHOCIN GEL FORMULATIONS AND USES THEREOF06/12/201816/006,660N/APublished

 

Patent Family 3

 

CountryTitleFiling DateApplication No.Patent No.Status 
United StatesMETHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS10/17/201916/656,129N/APublished
United StatesMETHODS AND COMPOSITIONS FOR TREATING ORAL MUCOSITIS10/17/2019PCT/US19/56772

 

N/APublished

 

Patent Family 4

 

CountryTitleFiling DateApplication No.Patent No.Status 
JapanAntimicrobial Compounds And Methods For Their Use05/03/20022009-120362JP5503900In Force
JapanAntimicrobial Compounds And Methods For Their Use05/03/20022013-210031JP5883838In Force
JapanProtonated/Acidified Nucleic Acids And Methods Of Use05/03/20022015-219286JP6097372In Force
United StatesAntimicrobial And Antiviral Compounds And Methods For Their Use12/30/199811/552951US7868162In Force

 

Patent Family 5

 

CountryTitleFiling DateApplication No.Patent No.Status 
United StatesOligonucleotide-Containing Pharmacological Compositions And Their Use07/10/200211/673486US8916529In Force

 

Patent Family 6

 

CountryTitleFiling DateApplication No.Patent No.Status 
AustraliaCompositions And Methods For The Treatment Of Muscle Wasting06/30/20062006345724AU2006345724In Force
CanadaAntisense Oligonucleotide Targeting Myostatin or Fox01 for Treatment of Muscle Wasting06/30/20062558160CA2558160In Force
ChinaCompositions And Methods For The Treatment Of Muscle Wasting06/24/2005

 

200510077730.2

 

CN100393320

 

In Force
United KingdomCompositions And Methods For The Treatment Of Muscle Wasting06/30/2006616790.2GB2441581In Force
United StatesCompositions And Methods For The Treatment Of Muscle Wasting06/30/200611/479112US8097596In Force

 

 

Patent Family 7

 

CountryTitleFiling DateApplication No.Patent No.Status 
United StatesCompositions And Methods For The Treatment Of Influenza Infection07/18/200611/458378US9574243In Force
United StatesCompositions And Methods For The Treatment Of Influenza Infection07/18/200615/400,797

 

US10378014

 

In Force